_components-of-new-drug-application-and-biologics-license-application-5of15-redi-may-29-30-2019-preview-1.jpg "Components of New Drug Application and Biologics License Application (5of15) REdI– May 29-30, 2019 from fda annual report Video Screenshot Preview 1")
Gallery_components-of-new-drug-application-and-biologics-license-application-5of15-redi-may-29-30-2019-preview-3.jpg "Components of New Drug Application and Biologics License Application (5of15) REdI– May 29-30, 2019 from fda annual report Video Screenshot Preview 3")
Gallery_components-of-new-drug-application-and-biologics-license-application-5of15-redi-may-29-30-2019-preview-hqdefault.jpg "Components of New Drug Application and Biologics License Application (5of15) REdI– May 29-30, 2019 from fda annual report Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 36 minutes 55 seconds
👁 View: 5.7K times
Play Audio:👁 View: 5.7K times
Description:
U.S. Food and Drug Administration
U.S. Food and Drug Administration
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_fda-regulatory-education-for-industry-redi-annual-conference-2023-plenary-drugs-day-1.webp "U.S. Food and Drug Administration")
⏲ 7 hours 42 minutes 41 seconds 👁 4.4K
_media-call-fdas-final-rule-on-laboratory-developed-tests-04-29-2024.webp "U.S. Food and Drug Administration")
⏲ 30 minutes 40 seconds 👁 794
_walkthrough-of-an-fda-clinical-investigator-site-inspection-12-14-redi-2017.webp "U.S. Food and Drug Administration")
⏲ 39 minutes 9 seconds 👁 2.9K
_anda-postapproval-changes-best-practices-and-strategies-to-avoid-common-quality-assessment-issues.webp "U.S. Food and Drug Administration")
⏲ 22 minutes 52 seconds 👁 2.2K
_the-fda-drug-development-process-glp-gmp-and-gcp-regulations.webp "GlobalCompliance Panel")
_fda-regulatory-education-for-industry-redi-annual-conference-2023-plenary-drugs-day-1.jpg)
_media-call-fdas-final-rule-on-laboratory-developed-tests-04-29-2024.jpg)
_walkthrough-of-an-fda-clinical-investigator-site-inspection-12-14-redi-2017.jpg)
_anda-postapproval-changes-best-practices-and-strategies-to-avoid-common-quality-assessment-issues.jpg)
_the-fda-drug-development-process-glp-gmp-and-gcp-regulations.jpg)
![[+]](/images/menu.gif){kind=small}